1(877) 627-3858

Lorem Ipsum Header

Lorem Ipsum dolor sit amet, consectetur adipiscing.
Request Demo

LYMPHATOUCH® AND LIGHTFORCE®

THE PERFECT COMBINATION

WHAT IS

LYMPHATOUCH®?

 

LymphaTouch®️ is a negative pressure medical device designed to improve rehabilitation outcomes through enhancing lymphatic flow. It helps reduce pain, swelling, and facial restrictions by stimulating lymphatic circulation, moving excess fluid from injured tissue to healthy regions of the body where the fluid can be absorbed and process naturally in the body.

LymphaTouch®️ treatment applications include pre- and post-operative swelling, scarring, lymphedema, acute injuries, fascial restrictions, recovery treatments, pain management and joint functionality.

 

NEGATIVE PRESSURE POSITIVE RESULTS

DESIGNED TO

IMPROVE

LYMPHATIC

CIRCULATION

How LymphaTouch®️ Works

  • Negative pressure stretches the skin and the tissue underneath, pulling on anchoring filaments to dilate the endothelial openings of lymph vessels.
  • Negative pressure creates movement of the anchoring filaments and the endothelial holes expand.
  • Metabolic waste moves into the lymphatic capillary network. Thus, activating the lymph flow.
  • Lymph and metabolic waste products that impede the healing process can then flow more easily from the interstitial space into lymph vessels. Excess fluid is carried away by the body’s own lymph transport mechanisms to re-join the venous circulation.
Laser treatment for arm with diagram

REHABILITATION

USAGES

Laser Therapy Treatment Areas

WHY

LYMPHATOUCH®?

SAFE AND COMFORTABLE
LIGHTWEIGHT AND EASY TO USE
ADJUSTABLE FUNCTIONS
MEASURABLE RESULTS
CLINICALLY PROVEN
Laser therapy for Shoulder Treatment

"For therapists who want one product that will provide a variety of treatment options, LymphaTouch® is definitely worth the investment. Easy to use, effective, and high patient satisfaction, this product is set apart from all others on the market."

Kathy McGinty, PTA, CLT John Hopkins Hospital, USA

NEGATIVE PRESSURE + LASER THERAPY

A POTENT APPROACH TO ADDRESSING INFLAMMATION

 
LT and LightForce Treatments

SCARS

LymphaTouch®

Mechanically pulls on fascial tissue, draws blood towards area (microcirculation), fibroblastic activity increase.

 LightForce®

Blood flow (NO release), excites fibroblastic activity (collagen laydown), promotes growth factors and neovascularization, as well as increasing macrophage activity to help remove damaged tissue.1,2,3,4,5,6,7 These factors all lead to improved wound tensile strength.8

Laser treatment for scars diagram

PAIN

LymphaTouch®

The precise physiological mechanism of pain alleviation by cupping therapy remains unclear, but there are several theories. First, chemical transmitters, such as serotonin, endorphin, and cortisol, which can block pain are secreted during cupping therapy, as occurs with acupressure or acupuncture, and play a role in ultimately reducing pain (Schulte, 1996). Second, nociceptor activation induces pain (Schaible et al., 2002), and it is suggested that cupping therapy alleviates pain by its anti-nociceptive effect and counter irritation (Michalsen et al., 2009). Third, all noninvasive and non-drug treatments have a placebo effect; a recent research finding suggested that a placebo-device is more effective in pain alleviation compared to placebo-pill (Kaptchuk et al., 2006).

 LightForce®

High power laser can reduce pain in minutes via interaction with C fibers and A-delta afferents.  PBM also reduces pain via it’s impact on neurotransmitters like serotonin and pain regulating chemicals like beta endorphins.9 Other factors that are impacted involve laser’s impact on nitric oxide (NO), ATP levels, and bradykinins which all impact the inflammatory cascade. Finally, PBM can influence the normalization of ion channels (K+, Na++, Ca++) which can impact the resting membrane potentials of sensory nerves.10 Combined, laser has several mechanisms that can improve pain complaints.

Pain diagram with laser treatment

SWELLING

LymphaTouch®

Increased microcirculation. Improved lymph flow via negative pressure.

 LightForce®

Improved ATP production helps reduce apoptosis (cell death) by helping maintain active pumps within the cell, which preserves healthier pH within the cell.11 Improved circulation via NO release helps oxygenate tissue and bring different white blood cells to the area to help with repairing injured tissue.12,13,14,15,16,17 Different inflammatory chemicals like bradykinins and prostaglandins are down regulated via PBM which helps reduce swelling.18,19,20

Swelling Diagrams 01

Learn More About LymphaTouch®

FEATURES

PATENTED AND UNIQUE TECHNOLOGY

PRODUCT BROCHURE

VERSATILE TREATMENT TOOL

CLINICAL PROOF BOOK

CLINICALLY PROVEN RESULTS

Experience LymphaTouch® Today

Fill out the form below to receive a quote or speak to a representative at 1.877.627.3858.

REFERENCES

1. Enhanced Leukocyte Infiltration (Karu 1991)

2. Increased Macrophage activity (Bansal et al 2003; Qin et al 1992; Bolton et al 1990)

3. Increased Neovascularization (Gladwin & Shiva 2009)

4. Increased Fibroblast Proliferation (Cagnie et al 2003; Abrahamse & Hawkins 2006)

5. Keratinocyte Proliferation (Graves et al 1990)

6. Early Epithelialization (Bayat et al 2005)

7. Growth Factors Increase (Benayahu et al 2005; Abrahamse et al 2008)

8. Greater wound tensile strength (Mester et al 1967)

9. Upon laser interaction with cells the following processes have been seen to occur:

• There is an increase in serotonin (5-HT) levels (Cassone et al 1993; Walker 1983; Cassone et al 1990). Serotonin acts as a chemical messenger that transmits nerve signals between nerve cells. Serotonin levels impact mood.

• There are also increases in Beta Endorphins, which decrease pain sensation. These increases (Montesinos 1988; Labajos 1988; Cramond et al 1994), can act to abolish pain at the receptor site.

• Nitric Oxide which is critical for normal action potential in impulse transmission activity in nerve cells is also increased upon laser stimulation (Mrowiec 1997). NO also has an effect on vasodilatation which enhances oxygenation.

• Bradykinins which can be prevalent in injured tissue, induce pain sensation by stimulating nociceptive afferents. Laser therapy has been shown to decrease these peptides reducing pain levels (Jimbo et al 1998).

10. Therapeutic lasers have also shown the following positive effects:

• Normalization of Ion Channels, Ca++, Na++, K+ proven to reduce pain levels (Alvarez-Leefmans et al 2005; Friedman & Lubart 1911).

• Blocked Depolarization of C-Fiber Afferent Nerves (Wakabayashi 1993): Therapeutic lasers can suppress the excitation of these fibers, particularly in low velocity neural pathways from nociceptors (Kawatani et al 1993).

• Increase Nerve Cell action potential: Injury or trauma can impair the resting potential of nerve cells leading to a very low threshold for pain. Laser treatment has shown to increase the resting potential closer to the norm of ~70 mV (Blom et al 2000).

• Increase release of Acetylcholine(Lupyr & Sergienko 1986; Mester et al 1977): Acetylcholine helps normalize nerve signal transmission in the autonomic and somatic pathways.

• Axonal Sprouting and Nerve Cell regeneration: Several studies have shown the lasers positive effects in nerve.

11. Enhancement of ATP (Friedman & Lubart 1911; Cui et al 2002; Casanassima et al 1984)

12. Stimulation of Vasodilatation (NO) (Gladwin & Shiva 2009)

13. Reduction in Interkeukin-1 (Albertini et al 2005)

14. Stabilization of the Cellular Membrane (Greco et al 2001)

15. Acceleration of Leukocytic Activity (Greguss et al 1978)

16. Increase Prostaglandin Synthesis (Abiko et al 2000; Harada et al 2004)

17. Enhanced Lymphocyte Response (Karu 1991)

18. Increased Angiogenesis (Krispel et al 2002; Belkin et al 1994)

19. Temperature Modulation (Kurokawa et al 1991; Maeda 1990)

20. Enhanced Superoxide Dismutase SOD levels (Eichler et al 2003; Eich